The clinicopathological characteristics of gonadatroph cell adenoma: A study of 118 cases

被引:38
作者
Ho, DMT
Hsu, CY
Ting, LT
Chiang, H
机构
[1] Dept. of Pathol. and Lab. Medicine, Veterans General Hospital-Taipei, Taipei
关键词
pituitary adenoma; gonadotroph; FSH; LH;
D O I
10.1016/S0046-8177(97)90005-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Gonadotroph cell adenoma was the most common pituitary adenoma, constituting 35% of the pituitary adenomas in our series of 339 patients with surgically removed pituitary adenomas from June 1987 to December 1995. The average age of these patients was 53 years, with a male predominance (1.5:1). The most common neurological symptoms were visual symptoms and headache. Amenorrhea and galactorrhea were recorded in 41% and 14%, respectively, of the female patients of reproductive age. Oncocytic change of varying degrees was seen in 69% of the tumors, and the average age of these patients (56 years) was older than those who had no such change (47 years) (P < .005). Five types of gonadotroph cell adenomas were recognized; they were tumors that contained (1) beta FSH, beta LH, and alpha SU, (2) beta FSH and PLH, (3) beta FSH and alpha SU, (4) beta FSH, and (5) alpha SU. The immunostaining of beta FSH-coontinnnng cells was usually diffuse, whereas staining of beta LH- or alpha SU-containing cells was usually focal. Double immunostaining showed the immunoreactive cells containing one or any combination of the gonadotropin subunits. Increases in serum gonadotropin levels were only seen in 35% of the patients with gonadotroph cell adenoma. There was no correlation between serum hormonal levels and immunostaining results. Of the 33 recurrent cases, significant decrease or total absence of immunoreactivity of one or more hormone subunits in subsequent biopsy specimens were seen in three cases. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:905 / 911
页数:7
相关论文
共 25 条
[1]   GONADOTROPIN-SECRETION INVITRO BY HUMAN PITUITARY NULL-CELL ADENOMAS AND ONCOCYTOMAS [J].
ASA, SL ;
GERRIE, BM ;
SINGER, W ;
HORVATH, E ;
KOVACS, K ;
SMYTH, HS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :1011-1019
[2]   FOLLICLE-STIMULATING HORMONE-SECRETING PITUITARY-ADENOMAS [J].
BECKERS, A ;
STEVENAERT, A ;
MASHITER, K ;
HENNEN, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (03) :525-528
[3]   PITUITARY ENLARGEMENT SECONDARY TO UNTREATED PRIMARY HYPOGONADISM [J].
BOWER, BF .
ANNALS OF INTERNAL MEDICINE, 1968, 69 (01) :107-+
[4]  
CAUGHEY J. E., 1957, AUSTRALASIAN ANN MED, V6, P93
[5]   CONTRIBUTION OF IMMUNOHISTOCHEMISTRY, ELECTRON-MICROSCOPY, AND CELL-CULTURE TO THE CHARACTERIZATION OF NONFUNCTIONING PITUITARY-ADENOMAS - A STUDY OF 40 CASES [J].
CROUE, A ;
BELDENT, V ;
ROUSSELET, MC ;
GUY, G ;
ROHMER, V ;
BIGORGNE, JC ;
SAINTANDRE, JP .
HUMAN PATHOLOGY, 1992, 23 (12) :1332-1339
[6]   MULTIPLE ENDOCRINE ORGAN REFRACTORINESS TO TROPHIC HORMONE STIMULATION - A PATIENT WITH AN ENLARGED SELLA TURCICA AND INCREASED FSH SECRETION [J].
GORDON, SJ ;
MOSES, AM .
ANNALS OF INTERNAL MEDICINE, 1965, 63 (02) :313-+
[7]  
HORVATH E, 1984, AM J PATHOL, V117, P429
[8]   GLYCOPROTEIN HORMONE GENES ARE EXPRESSED IN CLINICALLY NONFUNCTIONING PITUITARY-ADENOMAS [J].
JAMESON, JL ;
KLIBANSKI, A ;
BLACK, PM ;
ZERVAS, NT ;
LINDELL, CM ;
HSU, DW ;
RIDGWAY, EC ;
HABENER, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1472-1478
[9]   OVARIAN DWARFISM WITH PITUITARY TUMOR [J].
KELLY, LW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1963, 23 (01) :50-+
[10]   NONSECRETING PITUITARY-TUMORS [J].
KLIBANSKI, A .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1987, 16 (03) :793-804